Tumor Targeting by Conditioned Medium Derived From Human Amniotic Membrane: New Insight in Breast Cancer Therapy

Ameneh Jafari1, Mostafa Rezaei-Tavirani1, Hassan Niknejad2

  • 1Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Insights

Human amniotic membrane conditioned medium (hAM-CM) shows significant anti-cancer effects. This natural therapy inhibits breast cancer cell proliferation, migration, and invasion, offering a promising alternative treatment.

Area of Science:

  • Biomedical research
  • Cancer biology
  • Regenerative medicine

Background:

  • Traditional breast cancer treatments face challenges like drug resistance and severe side effects.
  • Novel therapeutic strategies are crucial for effective cancer management.
  • The human amniotic membrane (hAM) presents a potential source for new anti-cancer agents.

Purpose of the Study:

  • To investigate the anti-cancer properties of conditioned medium from the human amniotic membrane (hAM-CM) on breast cancer cells.
  • To evaluate the impact of hAM-CM on breast cancer cell viability, proliferation, apoptosis, migration, and invasion.

Main Methods:

  • Conditioned medium (hAM-CM) was prepared from human amniotic membrane cultures.
  • MTT, cell cycle, apoptosis, colony formation, and sphere assays were performed on breast cancer cell lines.
  • Scratch wound healing and Transwell assays assessed cell migration and invasion.

Main Results:

  • hAM-CM significantly reduced breast cancer cell viability in a dose-dependent manner.
  • hAM-CM induced apoptosis and necrosis, and inhibited cell migration and invasion.
  • Colony formation was suppressed, with morphological changes observed in treated cells.

Conclusions:

  • Conditioned medium from the human amniotic membrane demonstrates potent anti-proliferative and anti-metastatic effects on breast cancer cells.
  • hAM-CM is a promising natural candidate for developing novel breast cancer therapies.
  • Further research into hAM-CM could lead to innovative and less toxic cancer treatments.